Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

ClinicalTrials.gov ID: NCT00001118

Public ClinicalTrials.gov record NCT00001118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1 Infected Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the best dose of T-20, a new anti-HIV drug, to treat HIV-infected children. T-20, unlike other anti-HIV medications, lessens the ability of HIV to infect certain cells (T cells) in the body. Doctors hope to better treat HIV by adding T-20 to anti-HIV drug combinations that include 1 or 2 nucleoside reverse transcriptase inhibitors (NRTIs) plus a nonnucleoside reverse transcriptase inhibitor (NNRTI) and/or a protease inhibitor (PI).

Study identification

NCT ID
NCT00001118
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
24 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Nov 30, 2002
Last update posted
Oct 31, 2021

Ends 2002

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla California 920930672
Long Beach Memorial (Pediatric) Long Beach California 90801
Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles California 900276016
UCSF / Moffitt Hosp - Pediatric San Francisco California 941430105
Children's Hosp of Washington DC Washington D.C. District of Columbia 200102916
Howard Univ Hosp Washington D.C. District of Columbia 20060
Univ of Florida Health Science Ctr / Pediatrics Jacksonville Florida 32209
Univ of Miami (Pediatric) Miami Florida 33161
Tulane Univ / Charity Hosp of New Orleans New Orleans Louisiana 701122699
Children's Hosp of Boston Boston Massachusetts 021155724
Boston City Hosp / Pediatrics Boston Massachusetts 02118
Baystate Med Ctr of Springfield Springfield Massachusetts 01199
Univ of Massachusetts Med School Worcester Massachusetts 016550001
Children's Hosp of Michigan Detroit Michigan 48201
Univ of Medicine & Dentistry of New Jersey / Univ Hosp Newark New Jersey 071032714
North Shore Univ Hosp Great Neck New York 11021
Bellevue Hosp / New York Univ Med Ctr New York New York 10016
Metropolitan Hosp Ctr New York New York 10029
Harlem Hosp Ctr New York New York 10037
SUNY Health Sciences Ctr at Syracuse / Pediatrics Syracuse New York 13210
Bronx Lebanon Hosp Ctr The Bronx New York 10457
Bronx Municipal Hosp Ctr/Jacobi Med Ctr The Bronx New York 10461
Duke Univ Med Ctr Durham North Carolina 277103499
Med Univ of South Carolina Charleston South Carolina 294253312

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →